Cite
Suitable treatment period in patients with virological response during combination therapy of peginterferon and ribavirin for chronic hepatitis C.
MLA
Arase, Yasuji, et al. “Suitable Treatment Period in Patients with Virological Response during Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C.” Internal Medicine (Tokyo, Japan), vol. 47, no. 14, 2008, pp. 1301–07. EBSCOhost, https://doi.org/10.2169/internalmedicine.47.0797.
APA
Arase, Y., Suzuki, F., Sezaki, H., Suzuki, Y., Kawamura, Y., Kobayashi, M., Akuta, N., Hosaka, T., Yatsuji, H., Ikeda, K., Kobayashi, M., & Kumada, H. (2008). Suitable treatment period in patients with virological response during combination therapy of peginterferon and ribavirin for chronic hepatitis C. Internal Medicine (Tokyo, Japan), 47(14), 1301–1307. https://doi.org/10.2169/internalmedicine.47.0797
Chicago
Arase, Yasuji, Fumitaka Suzuki, Hitomi Sezaki, Yoshiyuki Suzuki, Yusuke Kawamura, Masahiro Kobayashi, Norio Akuta, et al. 2008. “Suitable Treatment Period in Patients with Virological Response during Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C.” Internal Medicine (Tokyo, Japan) 47 (14): 1301–7. doi:10.2169/internalmedicine.47.0797.